More than 50 independent pharmacies have filed a class action lawsuit against OptumRx, alleging the major pharmacy benefit manager failed to adhere to pharmacy claims reimbursement laws.
The pharmacies claim OptumRx paid them significantly less than chain retail pharmacies and reimbursed them below wholesale cost for generic drug stock.
The pharmacies also accuse OptumRx of leading network pharmacies into confidentiality agreements that obscured their unlawful practices.
Read the full news release here.
More articles on pharmacy:
California allows pharmacists to test patients for COVID-19
CVS to open 50 COVID-19 test sites this week
Sanofi CEO blasted for saying US should get coronavirus vaccine first
More articles on pharmacy:
California allows pharmacists to test patients for COVID-19
ICU Medical recalls IV solution
CVS to open 50 COVID-19 test sites this week
California allows pharmacists to test patients for COVID-19
ICU Medical recalls IV solution
CVS to open 50 COVID-19 test sites this week